Overview
Mitchell Garrison is a Hematologist practicing medicine in Omak, Washington.
Dr. Garrison is highly rated in 74 conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, and Primary Lymphoma of the Brain.
He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 2 clinical trials.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Accepted plan types not found. Please verify directly with the provider.
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- PPO
- EPO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
916 Koala Dr, Omak, WA 98841
1201 S Miller St, Wenatchee, WA 98801
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Frequently Asked Questions about Dr. Mitchell Garrison
How do I make an appointment with Dr. Mitchell Garrison?
You can book an appointment with Dr. Mitchell Garrison by calling their office at 509-826-1800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mitchell Garrison a top-rated expert for Chromophobe Renal Cell Carcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mitchell Garrison is classified as an Distinguished expert for Chromophobe Renal Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mitchell Garrison specialize in?
While Dr. Mitchell Garrison is a Hematology, they have specific expertise in Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Familial Wilms Tumor 2. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Mitchell Garrison participate in research or clinical trials?
Yes. Dr. Mitchell Garrison has published 4 articles and abstracts on conditions like Chromophobe Renal Cell Carcinoma. You can view a list of Dr. Mitchell Garrison's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mitchell Garrison accept my insurance?
Dr. Mitchell Garrison accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 509-826-1800 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Dr. Garrison isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Chromophobe Renal Cell CarcinomaDr. Garrison isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic Lymphocytic Leukemia (CLL)Dr. Garrison isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Classical Hodgkin LymphomaDr. Garrison isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Colorectal CancerDr. Garrison isDistinguished. Learn about Colorectal Cancer.
- Familial Wilms Tumor 2Dr. Garrison isDistinguished. Learn about Familial Wilms Tumor 2.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Adult Immune ThrombocytopeniaDr. Garrison isAdvanced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Garrison isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- AngiosarcomaDr. Garrison isAdvanced. Learn about Angiosarcoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Garrison isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Hepatic Porphyria (AHP)Dr. Garrison isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Garrison isExperienced. Learn about Acute Intermittent Porphyria.
- Acute Mountain SicknessDr. Garrison isExperienced. Learn about Acute Mountain Sickness.
- Acute Promyelocytic LeukemiaDr. Garrison isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Garrison isExperienced. Learn about Agranulocytosis.